These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22817745)

  • 1. BLF1, the first Burkholderia pseudomallei toxin, connects inhibition of host protein synthesis with melioidosis.
    Hautbergue GM; Wilson SA
    Biochem Soc Trans; 2012 Aug; 40(4):842-5. PubMed ID: 22817745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico prediction of host-pathogen protein interactions in melioidosis pathogen Burkholderia pseudomallei and human reveals novel virulence factors and their targets.
    Loaiza CD; Duhan N; Lister M; Kaundal R
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32444871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characterisation of Burkholderia pseudomallei Lethal Factor 1 (BLF1). A breakthrough against melioidosis].
    Hautbergue G
    Med Sci (Paris); 2012 Mar; 28(3):262-4. PubMed ID: 22480647
    [No Abstract]   [Full Text] [Related]  

  • 4. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?
    Lazar Adler NR; Govan B; Cullinane M; Harper M; Adler B; Boyce JD
    FEMS Microbiol Rev; 2009 Nov; 33(6):1079-99. PubMed ID: 19732156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Burkholderia pseudomallei infection and identification of novel virulence factors using a Caenorhabditis elegans host system.
    Gan YH; Chua KL; Chua HH; Liu B; Hii CS; Chong HL; Tan P
    Mol Microbiol; 2002 Jun; 44(5):1185-97. PubMed ID: 12068805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III Secretion in the Melioidosis Pathogen
    Vander Broek CW; Stevens JM
    Front Cell Infect Microbiol; 2017; 7():255. PubMed ID: 28664152
    [No Abstract]   [Full Text] [Related]  

  • 7. Unraveling the role of toxin-antitoxin systems in
    Chapartegui-González I; Stockton JL; Bowser S; Badten AJ; Torres AG
    Microbiol Spectr; 2024 Aug; 12(8):e0074824. PubMed ID: 38916327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid A Remodeling Is a Pathoadaptive Mechanism That Impacts Lipopolysaccharide Recognition and Intracellular Survival of Burkholderia pseudomallei.
    Norris MH; Somprasong N; Schweizer HP; Tuanyok A
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30037795
    [No Abstract]   [Full Text] [Related]  

  • 9. Toxin production by Burkholderia pseudomallei strains and correlation with severity of melioidosis.
    Haase A; Janzen J; Barrett S; Currie B
    J Med Microbiol; 1997 Jul; 46(7):557-63. PubMed ID: 9236739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An increase in p62/NBR1 levels in melioidosis patients of Sri Lanka exhibit a characteristic of potential host biomarker.
    Saikh KU; Ranji CM; Ulrich RG; Corea E; De Silva AD; Natesan M
    J Med Microbiol; 2020 Oct; 69(10):1240-1248. PubMed ID: 32815800
    [No Abstract]   [Full Text] [Related]  

  • 11. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The toxin/immunity network of Burkholderia pseudomallei contact-dependent growth inhibition (CDI) systems.
    Nikolakakis K; Amber S; Wilbur JS; Diner EJ; Aoki SK; Poole SJ; Tuanyok A; Keim PS; Peacock S; Hayes CS; Low DA
    Mol Microbiol; 2012 May; 84(3):516-29. PubMed ID: 22435733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increase in intracellular p62/NBR1 and persistence of Burkholderia mallei and B. pseudomallei in infected mice linked to autophagy deficiency.
    Saikh KU; Dankmeyer JL; Zeng X; Ulrich RG; Amemiya K
    Immun Inflamm Dis; 2019 Mar; 7(1):7-21. PubMed ID: 30569531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkholderia pseudomallei pathogenesis and survival in different niches.
    Yip CH; Ghazali AK; Nathan S
    Biochem Soc Trans; 2020 Apr; 48(2):569-579. PubMed ID: 32167134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy of Burkholderia pseudomallei BLF1-N and BLF1-C terminal domains against BLF1 toxin.
    Singh K; Singh AK; Uppalapati SR; Kingston JJ; Parida M
    Int Immunopharmacol; 2019 Dec; 77():105917. PubMed ID: 31675617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type III secretion system cluster 3 is required for maximal virulence of Burkholderia pseudomallei in a hamster infection model.
    Warawa J; Woods DE
    FEMS Microbiol Lett; 2005 Jan; 242(1):101-8. PubMed ID: 15621426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis).
    Wiersinga WJ; Wieland CW; Dessing MC; Chantratita N; Cheng AC; Limmathurotsakul D; Chierakul W; Leendertse M; Florquin S; de Vos AF; White N; Dondorp AM; Day NP; Peacock SJ; van der Poll T
    PLoS Med; 2007 Jul; 4(7):e248. PubMed ID: 17676990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems.
    Memišević V; Kumar K; Zavaljevski N; DeShazer D; Wallqvist A; Reifman J
    BMC Bioinformatics; 2016 Sep; 17():387. PubMed ID: 27650316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances and remaining uncertainties in the epidemiology of Burkholderia pseudomallei and melioidosis.
    Currie BJ
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):225-7. PubMed ID: 18166205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkholderia pseudomallei known siderophores and hemin uptake are dispensable for lethal murine melioidosis.
    Kvitko BH; Goodyear A; Propst KL; Dow SW; Schweizer HP
    PLoS Negl Trop Dis; 2012; 6(6):e1715. PubMed ID: 22745846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.